GlassScriptPhysician profile
Irina Jaeger
NPI 1023215936
$8,303.27
in general payments reported to CMS, 2019-2025
28 companies · $373 in 2025
The $373 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,875 · 2020: $813 · 2021: $2,166 · 2022: $535 · 2023: $464 · 2024: $78.49 · 2025: $373.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $915.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $915.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,583.49 | 2019-2025 | Lithovue, Moses 550 Dfl |
| Neotract INC. | $1,454.99 | 2019-2020 | |
| Rochester Medical Corporation | $729.36 | 2019-2022 | |
| Teleflex LLC | $501.38 | 2021-2023 | Urolift |
| C. R. Bard, INC. & Subsidiaries | $386.25 | 2019-2023 | Bard Urinary Drainage Bag |
| Calyxo, INC. | $350.00 | 2021 | |
| Astellas Pharma US INC | $289.34 | 2019-2024 | Myrbetriq, Veozah |
| Zyla Life Sciences, INC. | $166.85 | 2019-2020 | |
| Lumenis, INC | $132.20 | 2021 | |
| Procept Biorobotics Corporation | $117.49 | 2020-2025 | |
| Allergan, INC. | $71.68 | 2019-2021 | |
| Olympus America INC. | $68.57 | 2022-2025 | Itind System |
| Sumitomo Pharma America, INC. | $68.03 | 2023-2024 | Gemtesa |
| Dentsply Ih INC. | $67.66 | 2019-2021 | |
| Urovant Sciences INC | $33.46 | 2021-2022 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Antares Pharma, INC. | $30.62 | 2022 | |
| Coloplast Corp | $28.66 | 2021 | |
| Abbvie INC. | $24.67 | 2022 | |
| Bluewind Medical | $24.17 | 2025 | Revi |
| Blue Earth Diagnostics | $23.66 | 2020 | |
| Endo Pharmaceuticals INC. | $23.38 | 2023 | Xiaflex |
| Laborie Medical Technologies Corp. | $23.27 | 2025 | |
| Tolmar, INC. | $20.99 | 2025 | Jatenzo, Eligard |
| Verity Pharmaceuticals INC. | $20.00 | 2025 | Tlando |
| Janssen Biotech, INC. | $17.72 | 2025 | Erleada |
| Ambu INC. | $16.92 | 2022 | |
| Dentsply Ih Ab | $14.99 | 2023 | Lofric |
| Coopersurgical, INC. | $13.47 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Irina Jaeger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.